PAR · ALMKT.PA
Mauna Kea Technologies S.A.
€0.10-€0.00 (-0.31%)
Mauna Kea Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 58.36% below the high.
Loading market information…
PAR · MLLAB.PA · EUR
Stock price, dividends
Quote as of Oct 23, 2026, 02:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Media Lab S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 45.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Media Lab S.p.A.’s forward annual dividend is €0.34 per share, paid semi-annual. The forward yield is 15.35% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Media Lab S.p.A. specializes in providing information technology solutions tailored for the dental industry. The company's offerings include Implant 3D, a sophisticated software designed for planning dental implants and generating surgical guides, which empowers users to conduct three-dimensional implant simulations directly on their personal computers. Furthermore, Media Lab S.p.A. supplies various instruments and accessories crucial for implantology and guided surgical techniques, as well as delivering professional training programs. Established in 1994, the company's headquarters are situated in Milan, Italy.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
€0.10-€0.00 (-0.31%)
Mauna Kea Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 58.36% below the high.
€5.55+€0.05 (+0.91%)
Euromedis Groupe’s quoted price sits in the upper half of its reported 52-week range, 9.76% below the high.
€0.85+€0.01 (+1.19%)
Biosynex S.A.’s quoted price sits in the lower half of its reported 52-week range, 45.86% below the high.
€0.14+€0.02 (+16.5%)
TME Pharma N.V.’s quoted price sits in the upper half of its reported 52-week range, 19.93% below the high.
€0.20-€0.00 (-0.98%)
Intrasense S.A.’s quoted price sits in the lower half of its reported 52-week range, 57.11% below the high.
€0.09+€0.00 (+4.0%)
SpineGuard S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.88% below the high.
€0.10-€0.00 (-2.44%)
AMA Corporation Plc’s quoted price sits in the lower half of its reported 52-week range, 50.98% below the high.
€3.74-€0.20 (-5.08%)
Plant Advanced Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 57.79% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
